ONDRÁČEK, Jakub, Pavel FADRUS, Jiří ŠÁNA, Andrej BEŠŠE, Tomáš LOJA, Marek VEČEŘA, Lenka RADOVÁ, Martin SMRČKA, Pavel ŠLAMPA and Ondřej SLABÝ. Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells. Anticancer Research. Athens: The International Institute of Anticancer Research, 2017, vol. 37, No 3, p. 1099-1104. ISSN 0250-7005. Available from: https://dx.doi.org/10.21873/anticanres.11422.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Global MicroRNA Expression Profiling Identifies Unique MicroRNA Pattern of Radioresistant Glioblastoma Cells
Authors ONDRÁČEK, Jakub (203 Czech Republic), Pavel FADRUS (203 Czech Republic, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Andrej BEŠŠE (703 Slovakia, belonging to the institution), Tomáš LOJA (703 Slovakia, belonging to the institution), Marek VEČEŘA (703 Slovakia, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution), Pavel ŠLAMPA (203 Czech Republic, belonging to the institution) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Anticancer Research, Athens, The International Institute of Anticancer Research, 2017, 0250-7005.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.865
RIV identification code RIV/00216224:14740/17:00095642
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.21873/anticanres.11422
UT WoS 000397129600019
Keywords in English Glioblastoma; radioresistance; microRNA
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 28/3/2018 15:55.
Abstract
Glioblastoma multiforme ( GBM) is the most aggressive intracranial tumor characterized with infaust prognosis. Despite advances in neurosurgical and radiotherapeutic techniques and chemotherapy, the median overall survival ranges between 12-15 months from diagnosis. The main cause of treatment failure is considered the presence of tumor cells resistant to conventional therapy, mainly radiotherapy. MicroRNAs (miRNAs) are small, non-coding RNAs that function as post-transcriptional regulators of gene expression and have been repeatedly proven to play important roles in pathogenesis and biological features of many cancers, including GBM and its radioresistant phenotype. In our study, we established radioresistant cells from the commonly used human GBM cell lines T98G, U87MG and U251. Consequently, we performed global miRNA expression profiling in both radioresistant and parental cell lines and identified 113 miRNAs with significantly different expression (p < 0.05) between these two groups (73 miRNAs were up-regulated, 40 miRNAs were down-regulated). Some of these miRNAs have been previously described in relation to ionizing radiation, and others were herein identified for the first time. We believe that after deeper functional investigation of identified miRNAs in relation to radioresistance, these miRNAs present potential predictive biomarkers or therapeutic targets in GBM.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NV15-33158A, research and development projectName: Nová úroveň molekulární taxonomie glioblastomu založená na expresních profilech dlouhých nekódujících RNA: implikace pro diagnostiku a terapii
NV15-34553A, research and development projectName: Využití mikroRNA v mozkomíšním moku pro diagnostiku mozkových nádorů
PrintDisplayed: 14/7/2024 14:41